Rate My Professor Brett Collins

Professor Brett Collins is a leading structural biologist at the University of Queensland's Institute for Molecular Bioscience, where he heads the Molecular Trafficking Lab and directs the Centre for Cell Biology of Chronic Disease. An NHMRC Leadership Fellow, he earned his PhD from Macquarie University in 2001. His career trajectory includes NHMRC Career Development Fellowships from 2006 to 2011 and 2014 to 2017, as well as an Australian Research Council Future Fellowship. Collins has made seminal contributions to understanding membrane trafficking, particularly through high-resolution structural studies of key protein complexes using X-ray crystallography, cryo-electron microscopy, and NMR spectroscopy. His work elucidates how proteins and lipids control endosomal sorting, receptor transport, and organelle homeostasis, with implications for diseases including Alzheimer's, Parkinson's, cancer, inflammation, and pathogen invasion. Notable achievements include defining the molecular architecture of the AP2 clathrin adaptor complex central to endocytosis and pioneering insights into retromer, sorting nexins (SNX), Commander, and cavin proteins in caveola biogenesis.

Collins has authored over 75 publications cited more than 3,100 times, appearing in top journals such as Cell, Nature, Science, and PNAS. Key papers include 'Molecular architecture and functional model of the endocytic AP2 complex' (Cell, 2002), 'Neuropilin-1 is a host factor for SARS-CoV-2 infection' (Science, 2020), 'Retriever is a multiprotein complex for retromer-independent endosomal cargo recycling' (Nature Cell Biology, 2017), 'Insights into the PX domain and SNX protein families: structures, functions and roles in disease' (Biochemical Journal, 2012), and 'Cavin family proteins and the assembly of caveolae' (Journal of Cell Science, 2015). His accolades encompass the University of Queensland Research Excellence Award (2008), Emerging Leader Award from the Australia and New Zealand Society for Cell and Developmental Biology (2015), and Merck Research Medal from the Australian Society for Biochemistry and Molecular Biology (2016). As President of the Queensland Protein Group, Collins influences the field through leadership and media expertise on topics like neurodegeneration and cryo-EM. His research drives therapeutic strategies targeting trafficking defects in chronic diseases.